Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M401177200 on April 1, 2004

J. Biol. Chem., Vol. 279, Issue 25, 25966-25977, June 18, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/25/25966    most recent
M401177200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kockx, M.
Right arrow Articles by Kritharides, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kockx, M.
Right arrow Articles by Kritharides, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Apolipoprotein A-I-stimulated Apolipoprotein E Secretion from Human Macrophages Is Independent of Cholesterol Efflux*

Maaike Kockx,a Kerry-Anne Rye,b Katharina Gaus,a Carmel M. Quinn,a Janelle Wright,a Timothy Sloane,a Dimitri Sviridov,c Ying Fu,c David Sullivan,d John R. Burnett,e Stephan Rust,f Gerd Assmann,f G. M. Anantharamaiah,g Mayakonda N. Palgunachari,g Sissel Lund Katz,h Michael C. Phillips,h Roger T. Dean,i Wendy Jessup,a and Leonard Kritharidesabjk

From the a Macrophage Biology Group, Centre for Vascular Research, University of New South Wales, Sydney 2052, Australia, b The Heart Research Institute, Sydney 2050, Australia, the c Baker Heart Research Institute, Melbourne 8008, Australia, the d Department of Clinical Biochemistry, Royal Prince Alfred Hospital, University of Sydney, Sydney 2050, Australia, the e Department of Core Clinical Pathology and Biochemistry, Royal Perth Hospital, School of Medicine & Pharmacology, University of Western Australia, Perth 6847, Australia, the f Institut für Arterioskleroseforschung an der Westfälischen Wilhelms-Universität Münster, Münster 48149, Germany, the g University of Alabama at Birmingham Medical Center, Birmingham, Alabama 35294, the hChildren's Hospital of Philadelphia, Stokes Research Institute, Philadelphia, Pennsylvania 19104-4318, the i University of Canberra, Australian Capital Territory 2601, Australia, and the j Department of Cardiology Concord Hospital, University of Sydney, Sydney 2139, Australia

Apolipoprotein A-I (apoA-I)-mediated cholesterol efflux involves the binding of apoA-I to the plasma membrane via its C terminus and requires cellular ATP-binding cassette transporter (ABCA1) activity. ApoA-I also stimulates secretion of apolipoprotein E (apoE) from macrophage foam cells, although the mechanism of this process is not understood. In this study, we demonstrate that apoA-I stimulates secretion of apoE independently of both ABCA1-mediated cholesterol efflux and of lipid binding by its C terminus. Pulse-chase experiments using 35S-labeled cellular apoE demonstrate that macrophage apoE exists in both relatively mobile (Em) and stable (Es) pools, that apoA-I diverts apoE from degradation to secretion, and that only a small proportion of apoA-I-mobilized apoE is derived from the cell surface. The structural requirements for induction of apoE secretion and cholesterol efflux are clearly dissociated, as C-terminal deletions in recombinant apoA-I reduce cholesterol efflux but increase apoE secretion, and deletion of central helices 5 and 6 decreases apoE secretion without perturbing cholesterol efflux. Moreover, a range of 11- and 22-mer {alpha}-helical peptides representing amphipathic {alpha}-helical segments of apoA-I stimulate apoE secretion whereas only the C-terminal {alpha}-helix (domains 220–241) stimulates cholesterol efflux. Other {alpha}-helix-containing apolipoproteins (apoA-II, apoA-IV, apoE2, apoE3, apoE4) also stimulate apoE secretion, implying a positive feedback autocrine loop for apoE secretion, although apoE4 is less effective. Finally, apoA-I stimulates apoE secretion normally from macrophages of two unrelated subjects with genetically confirmed Tangier Disease (mutations C733R and c.5220–5222delTCT; and mutations A1046D and c.4629–4630insA), despite severely inhibited cholesterol efflux. We conclude that apoA-I stimulates secretion of apoE independently of cholesterol efflux, and that this represents a novel, ABCA-1-independent, positive feedback pathway for stimulation of potentially anti-atherogenic apoE secretion by {alpha}-helix-containing molecules including apoA-I and apoE.


Received for publication, February 3, 2004 , and in revised form, March 29, 2004.

* This work was supported by grants in aid (to W. J. and L. K.) and Fellowship (to W. J.) from the National Health and Medical Research Council of Australia, by National Institutes of Health Grants HL22633 and HL34343, the National Heart Foundation of Australia, and the Australian Research Council (to K. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

k To whom correspondence should be addressed: Macrophage Biology Group, Centre for Vascular Research, 4th Floor Wallace Wurth Bldg., University of New South Wales, UNSW, Sydney, NSW 2052, Australia. Tel.: 61-2-93851179; Fax: 61-2-93851389; E-mail: l.kritharides{at}unsw.edu.au.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
D. R. Riddell, H. Zhou, K. Atchison, H. K. Warwick, P. J. Atkinson, J. Jefferson, L. Xu, S. Aschmies, Y. Kirksey, Y. Hu, et al.
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
J. Neurosci., November 5, 2008; 28(45): 11445 - 11453.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. R. Su, J. L. Blakemore, Y. Zhang, M. F. Linton, and S. Fazio
Lentiviral Transduction of ApoAI Into Hematopoietic Progenitor Cells and Macrophages: Applications to Cell Therapy of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1439 - 1446.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Kockx, W. Jessup, and L. Kritharides
Regulation of Endogenous Apolipoprotein E Secretion by Macrophages
Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1060 - 1067.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Kockx, D. L. Guo, T. Huby, P. Lesnik, J. Kay, T. Sabaretnam, E. Jary, M. Hill, K. Gaus, J. Chapman, et al.
Secretion of Apolipoprotein E From Macrophages Occurs via a Protein Kinase A and Calcium-Dependent Pathway Along the Microtubule Network
Circ. Res., September 14, 2007; 101(6): 607 - 616.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Fan, S. Qiu, C. D. Overton, P. G. Yancey, L. L. Swift, W. G. Jerome, M. F. Linton, and S. Fazio
Impaired Secretion of Apolipoprotein E2 from Macrophages
J. Biol. Chem., May 4, 2007; 282(18): 13746 - 13753.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. G. Yancey, H. Yu, M. F. Linton, and S. Fazio
A Pathway-Dependent on ApoE, ApoAI, and ABCA1 Determines Formation of Buoyant High-Density Lipoprotein by Macrophage Foam Cells
Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1123 - 1131.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Liu, M. R. Hojjati, C. M. Devlin, I. H. Hansen, and X.-C. Jiang
Macrophage Phospholipid Transfer Protein Deficiency and ApoE Secretion: Impact on Mouse Plasma Cholesterol Levels and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 190 - 196.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Abildayeva, P. J. Jansen, V. Hirsch-Reinshagen, V. W. Bloks, A. H. F. Bakker, F. C. S. Ramaekers, J. de Vente, A. K. Groen, C. L. Wellington,, F. Kuipers, et al.
24(S)-Hydroxycholesterol Participates in a Liver X Receptor-controlled Pathway in Astrocytes That Regulates Apolipoprotein E-mediated Cholesterol Efflux
J. Biol. Chem., May 5, 2006; 281(18): 12799 - 12808.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. C. Gelissen, M. Harris, K.-A. Rye, C. Quinn, A. J. Brown, M. Kockx, S. Cartland, M. Packianathan, L. Kritharides, and W. Jessup
ABCA1 and ABCG1 Synergize to Mediate Cholesterol Export to ApoA-I
Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 534 - 540.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. N. Glaros, W. S. Kim, C. M. Quinn, J. Wong, I. Gelissen, W. Jessup, and B. Garner
Glycosphingolipid Accumulation Inhibits Cholesterol Efflux via the ABCA1/Apolipoprotein A-I Pathway: 1-PHENYL-2-DECANOYLAMINO-3-MORPHOLINO-1-PROPANOL IS A NOVEL CHOLESTEROL EFFLUX ACCELERATOR
J. Biol. Chem., July 1, 2005; 280(26): 24515 - 24523.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement